Med-X, the parent company of Nature-Cide and a pioneer of eco-friendly pest control and wellness solutions, launched a Regulation A+ equity financing round, aiming to raise up to $10 million through the sale of common stock at $4.00 per share with a $600 minimum.
CEO Matthew Mills emphasizes that the Regulation A+ public offering should enable Med-X to accelerate growth and pursue a direct listing on a national stock exchange, with aspirations to join the NASDAQ under the reserved symbol “MXRX.” The company plans to engage with the investment community through presentations at various investor conferences, supported by strategic partnerships with investor relations firm MZ Group and investment bank Maxim Group.
Nature-Cide is an eco-friendly pest control solution derived from various natural essential oils. A 2024 article in the journal Agriculture highlights the biocidal, repellent and antifeedant effects of essential oils, noting their potential as natural alternatives to synthetic pesticides.
Med-X continues to expand Nature-Cide’s global footprint, with recent product placements in Thailand, Singapore and New Zealand. The company is also actively pursuing registrations in multiple Asian countries, Australia, the UAE, Saudi Arabia and South America.
About Med-X, the parent company of Nature-Cide
Med-X Inc. is an innovator of biological pest control solutions addressing both consumer and professional markets globally. Nature-Cide, its flagship product line, uses all-natural formulations to kill or repel a wide variety of pests and can be used for pest control in residential, commercial and agricultural settings.
Leave A Comment